LIVN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

LivaNova PLC · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 80.14 USD
2.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 14.5% above the Trend Line and sits at 88.4% of its 52-week range. The latest completed week returned 2.5%, after a -4.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is mixed with 37/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 61 out of 100
Latest Close 80.14 USD 31 Jul 2026
1W Return 2.5% latest completed week
4W Return -4.2% short-term follow-through
12W Return 11.5% quarterly tape
Trend Breadth 98.1% 51 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 51-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 40.12% based on similar historical setup states.
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.5% Latest completed week; four-week move -4.2%. Indicator stack 99/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.12% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 37/100 conviction; expected move 10.9%. News sentiment 52/100 67 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 14.5% above the Trend Line and sits at 88.4% of its 52-week range. The latest completed week returned 2.5%, after a -4.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9712-week average 0.74

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.97Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.2% over four weeks, 11.5% over 12 weeks, and 94.8% over one year. The current trend has remained active for 51 consecutive weeks.

Performance by holding period

1W2.5%
4W-4.2%
12W11.5%
26W22.0%
52W94.8%
Active trend streak51 weeks
Active weeks in one year51
Trend breadth98.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.58Latest activity-pressure read.
Pressure change-54.9%Four-week change in activity pressure.
Leadership14.92Latest relative-leadership reading.
RS change-22.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength56/100Blend of value, momentum, and quality. Underlying universe rank 45; rank 1 is best.
Value12/100Relative valuation strength. Underlying universe rank 89; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum93/100Medium-term price momentum. Underlying universe rank 8; rank 1 is best.
Growth73/100Revenue and earnings growth. Underlying universe rank 28; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
40.1x
Price divided by trailing earnings.
Price / sales
3.0x
Market value relative to trailing revenue.
EV / EBITDA
19.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
67.6%
Gross profit retained from each unit of revenue.
Operating margin
12.0%
Operating profit retained from revenue.
Free-cash-flow margin
23.0%
Free cash flow generated from revenue.
Return on invested capital
15.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
32.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

LIVN shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 1.00, expected move of 10.9%, and Sharemaestro trend signal active.

Conviction37/100
Expected move10.9%
Put/call volume1.00
Pressure10
Speculation8
Volatility78
Trend agreement87
Open options detail
Insider activity4 / 16

4 acquisitions and 16 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 67 relevant articles.

11 positive · 52 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move10.9%Nearest-chain priced movement where available.
52-week drawdown-6.0%Distance below the 52-week high.
13-week volatility5.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+17.8%Week of 8 May.
Worst week-9.6%Week of 6 Mar.
Latest week+2.5%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses10
Sharp losses4
Recent vol5.9%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew5.7% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape65/100

Trend, activity pressure, participation, and risk combine to a 65/100 tape read.

 Indicator analysis87/100

Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 12/12.

Activity pressure 0.97; 1 reversal markers Next-Week ExpectancyNegative 40.12%

Next-week expectancy is negative with a 40.12% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors62/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 58; Small Cap Core rank 91 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options57/100

LIVN shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 1.00, expected move of 10.9%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 10.9% Sentiment52/100

Weighted news tone is neutral across 67 relevant articles.

LivaNova PLC (LIVN) Financial Health: Profitability & Balance Sheet Analysis Insiders4 / 16

4 acquisitions and 16 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202680.14 USD2.5%70.01 USD54.33 USD0.5814.922.7MOn
24 Jul 202678.19 USD-3.1%69.36 USD54.18 USD0.7413.652.6MOn
17 Jul 202680.70 USD-2.3%68.85 USD54.05 USD1.0616.243.1MOn
10 Jul 202682.56 USD-1.3%68.26 USD53.87 USD1.1714.882.8MOn
3 Jul 202683.62 USD0.2%67.60 USD53.68 USD1.2819.242.7MOn
26 Jun 202683.43 USD6.3%66.92 USD53.47 USD1.1320.804.7MOn
19 Jun 202678.50 USD-1.1%66.27 USD53.26 USD0.879.283.7MOn
12 Jun 202679.39 USD9.7%65.49 USD53.07 USD0.6613.914.3MOn
5 Jun 202672.36 USD-2.0%64.69 USD52.88 USD0.346.713.3MOn
29 May 202673.80 USD-0.0%63.96 USD52.72 USD0.374.263.0MOn
22 May 202673.83 USD5.5%63.26 USD52.55 USD0.057.673.1MOn
15 May 202670.00 USD-2.6%62.62 USD52.36 USD-0.213.753.8MOn
8 May 202671.86 USD17.8%62.08 USD52.20 USD-0.306.456.9MOn
1 May 202661.00 USD-5.0%61.38 USD52.04 USD-0.62-4.474.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.